Lithuania, Markets and Companies, Medicine, Mergers and take-overs, Technology

Fermentas will be integrated into Thermo Fisher Scientific's Analytical Technologies Segment.

With Fermentas' broad range of high-quality molecular and cellular biology research tools, including reagents, enzymes and kits, Thermo Fisher can offer a complete workflow for genomics research while building on its platform of PCR and qPCR tools and resources.

Thermo Fisher Scientific Inc. has approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. The enterprise’s products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.